Previous 10 | Next 10 |
SWK Holdings (NASDAQ: SWKH ) : Q2 GAAP EPS of $0.07 beats by $0.14 . More news on: SWK Holdings Corporation, Earnings news and commentary, Financial stocks news, , Read more ...
DALLAS , Aug. 17, 2020 /PRNewswire/ -- Corporate Highlights Rajiv Khosla , Ph.D. appointed as Chief Executive Officer of Enteris BioPharma Repurchased $1.0 million of common stock during the three-month span ended June 30, 2020 SWK Holdings Added to Russell 3000™, 2...
DALLAS , Aug. 14, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live audio webcast on Monday, August 17, 2020 , at 10:00 a.m. ET , to discuss its corporate...
NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and interactive ...
DALLAS , June 29, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today its addition to the broad-market Russell 3000 ® Index, the Russell 2000 ® Index and the Russell Mic...
The following slide deck was published by SWK Holdings Corporation in conjunction with this Read more ...
DALLAS , June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will present via webcast at the Life Sciences Investor Forum being held June 25, 2020 . Details of SWK...
NEW YORK, June 23, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its second quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentatio...
BOONTON, N.J. , June 9, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that John Vretto...
BOONTON, N.J. , June 2, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company is pa...
News, Short Squeeze, Breakout and More Instantly...
SWK Holdings Corporation Company Name:
SWKH Stock Symbol:
OTCMKTS Market:
SWK Holdings Corporation Website:
Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of ...
2024-06-24 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate Highlights First quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023 First quarter 2024 finance r...